Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
Glaucoma, Glaucoma Suspect, Diabetic Retinopathy
About this trial
This is an interventional other trial for Glaucoma
Eligibility Criteria
Inclusion Criteria:
- African-American, Hispanic, or Asian individuals over age 40
- Caucasian individuals over age 65
- Individuals of any ethnicity, over age 40 with a family history of glaucoma
- Individuals of any ethnicity, over age 40 with diabetes
- Individuals who meet one of the above criteria who have not seen an ophthalmologist in the past year
Exclusion Criteria:
Any patient with previously diagnosed glaucoma, glaucoma suspect, or eye diseases who is currently being followed by an ophthalmologist
-
Sites / Locations
- Wills Eye Glaucoma Service
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Phase 1: Telemedicine Screening Participants
Phases 2 and 3: Enhanced Intervention Group
Phases 2 and 3: Usual Care Group
Participants across the Philadelphia, PA region were invited to participate in free eye screenings at primary care physician offices or health centers. Screenings included images of optic nerve and macula using non-contact, autofocus, hand-held fundus cameras (Volk Optical, Mentor, Ohio, USA) and measuring Intraocular Pressure (IOP) in millimeters of mercury (mm Hg) with non-contact rebound tonometers TA01I (ICare, Helsinki, Finland).
From eye screening results (visit 1), Phase 2 includes participants requiring further evaluation received comprehensive eye exam to confirm diagnosis (visit 2). Following confirmation diagnosis, patients were randomized to the Enhanced Intervention Group and were referred to a general ophthalmologist for follow-up eye care. Patient navigation and a social worker and referred to a general ophthalmologist close to the current health center or primary care physician office where they received the non dilated eye exam. Prior to all follow-up visits, patients in the Enhanced Intervention Group were provided a scheduled appointment and received a personal phone call reminding them to attend. Patients received necessary interpretation services and educational materials. Phase 3. Includes following this group over a 5 year period for adherence to eye care.
From eye screening results (visit 1), Phase 2 includes participants requiring further evaluation received comprehensive eye exam to confirm diagnosis (visit 2). Following confirmation diagnosis, patients were randomized to the Usual Care Group and were referred to a general ophthalmologist for follow-up eye care. These patients were scheduled for their initial follow-up visit based on the recommendations of our study physicians so the research team was able to track outcomes. This group represents a realistic choice currently available for patients. Practice patterns vary depending on the resources, staff time, and services available within each local ophthalmology practice. Phase 3. Includes following this group over a 5 year period for adherence to eye care.